Comments on "Radiotherapy alone versus concurrent chemoradiotherapy in patients with stage II and T3N0 nasopharyngeal carcinoma with adverse features: A propensity score-matched cohort study".
Autor: | Beduk Esen CS; Department of Radiation Oncology, Prof. Dr. Cemil Taşcıoğlu City Hospital, Istanbul, Turkey. Electronic address: selengebedk@gmail.com., Can GN; Department of Radiation Oncology, Prof. Dr. Cemil Taşcıoğlu City Hospital, Istanbul, Turkey., Akkus Yildirim B; Department of Radiation Oncology, Prof. Dr. Cemil Taşcıoğlu City Hospital, Istanbul, Turkey. |
---|---|
Jazyk: | angličtina |
Zdroj: | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Aug; Vol. 197, pp. 110292. Date of Electronic Publication: 2024 Apr 20. |
DOI: | 10.1016/j.radonc.2024.110292 |
Abstrakt: | Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. |
Databáze: | MEDLINE |
Externí odkaz: |